JP2022529784A5 - - Google Patents

Info

Publication number
JP2022529784A5
JP2022529784A5 JP2021562003A JP2021562003A JP2022529784A5 JP 2022529784 A5 JP2022529784 A5 JP 2022529784A5 JP 2021562003 A JP2021562003 A JP 2021562003A JP 2021562003 A JP2021562003 A JP 2021562003A JP 2022529784 A5 JP2022529784 A5 JP 2022529784A5
Authority
JP
Japan
Prior art keywords
peptide
cell
composition according
permeable
cargo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021562003A
Other languages
English (en)
Japanese (ja)
Other versions
JP7715638B2 (ja
JP2022529784A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/028572 external-priority patent/WO2020214846A1/en
Publication of JP2022529784A publication Critical patent/JP2022529784A/ja
Publication of JP2022529784A5 publication Critical patent/JP2022529784A5/ja
Application granted granted Critical
Publication of JP7715638B2 publication Critical patent/JP7715638B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021562003A 2019-04-17 2020-04-16 分子を細胞内送達するためのペプチドおよびナノ粒子 Active JP7715638B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1904115 2019-04-17
FR1904115 2019-04-17
PCT/US2020/028572 WO2020214846A1 (en) 2019-04-17 2020-04-16 Peptides and nanoparticles for intracellular delivery of molecules

Publications (3)

Publication Number Publication Date
JP2022529784A JP2022529784A (ja) 2022-06-24
JP2022529784A5 true JP2022529784A5 (enExample) 2023-04-24
JP7715638B2 JP7715638B2 (ja) 2025-07-30

Family

ID=72837882

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021562003A Active JP7715638B2 (ja) 2019-04-17 2020-04-16 分子を細胞内送達するためのペプチドおよびナノ粒子

Country Status (9)

Country Link
US (2) US12357695B2 (enExample)
EP (1) EP3955967A4 (enExample)
JP (1) JP7715638B2 (enExample)
CN (1) CN114007654A (enExample)
AU (1) AU2020259449A1 (enExample)
CA (1) CA3137137A1 (enExample)
IL (1) IL287321A (enExample)
MX (2) MX2021012740A (enExample)
WO (1) WO2020214846A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3955967A4 (en) 2019-04-17 2023-06-07 Aadigen, LLC PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF MOLECULES
WO2023081893A1 (en) * 2021-11-08 2023-05-11 Entrada Therapeutics, Inc. Intracellular targeting of oligonucleotides
WO2023111213A1 (en) 2021-12-16 2023-06-22 Rdp Pharma Ag Cell penetrating polypeptides (cpps) and their use in human therapy
WO2023248846A1 (ja) * 2022-06-22 2023-12-28 東亞合成株式会社 キャリアペプチドフラグメント及びその利用
NL2033185B1 (en) * 2022-09-29 2024-04-08 Stichting Vu Compounds for rna stabilisation and delivery
WO2024187174A2 (en) * 2023-03-09 2024-09-12 Aadigen, Llc Compositions for treating cancer with kras mutations and uses thereof
EP4480497A1 (en) 2023-06-21 2024-12-25 RDP Pharma AG Bio-conjugates for oncology
WO2025193628A2 (en) * 2024-03-09 2025-09-18 Aadigen, Llc Compositions for treating cancer with kras mutations and uses thereof
FR3163973A1 (fr) 2024-06-27 2026-01-02 Safran Aircraft Engines Compresseur axial a traitement de carter pour une turbomachine d’aeronef
CN119954937B (zh) * 2024-12-26 2025-09-12 东北农业大学 一种源自节肢蛋白的抗菌肽及其制备方法和应用

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003295600A1 (en) 2002-11-14 2004-06-15 Dharmacon, Inc. Functional and hyperfunctional sirna
US7514530B2 (en) 2004-04-26 2009-04-07 Centre National De La Recherche Scientifique Peptide carrier for delivering siRNA into mammalian cells
US7579318B2 (en) 2005-12-06 2009-08-25 Centre De La Recherche De La Scientifique Cell penetrating peptides for intracellular delivery of molecules
EP2331566B1 (en) 2008-08-26 2015-10-07 City of Hope Method and compositions for enhanced anti-tumor effector functioning of t cells
US8889394B2 (en) 2009-09-07 2014-11-18 Empire Technology Development Llc Multiple domain proteins
DK2631291T3 (da) 2010-10-22 2019-06-11 Olix Pharmaceuticals Inc Nukleinsyremolekyler, der inducerer rna-interferens, og anvendelser deraf
WO2012129352A1 (en) 2011-03-21 2012-09-27 Yale University The kras variant and tumor biology
WO2012137036A1 (en) 2011-04-04 2012-10-11 Centre National De La Recherche Scientifique Cell penetrating peptides for intracellular delivery of molecules
EP3375457B1 (en) 2011-11-24 2020-06-24 Positec Power Tools (Suzhou) Co., Ltd Peptide sequence design and use thereof for peptide-mediated sirna delivery
JP2013212052A (ja) 2012-03-30 2013-10-17 Yale Univ Krasバリアントおよび腫瘍生物学
US9254311B2 (en) 2012-04-02 2016-02-09 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins
WO2013151665A2 (en) 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of proteins associated with human disease
WO2013150338A1 (en) 2012-04-04 2013-10-10 Centre National De La Recherche Scientifique Stapled cell penetrating peptides for intracellular delivery of molecules
RU2766608C2 (ru) 2012-04-11 2022-03-15 Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез Химерные антигенные рецепторы, нацеленные на антиген созревания b-клеток
ES2981865T3 (es) 2012-07-11 2024-10-10 Gemvax & Kael Co Ltd Conjugado que comprende un péptido de penetración celular y composiciones que comprenden el mismo
CA2878314A1 (en) 2012-07-16 2014-01-23 Kyowa Hakko Kirin Co., Ltd. Rnai pharmaceutical composition for suppressing expression of kras gene
WO2014053880A1 (en) * 2012-10-04 2014-04-10 Centre National De La Recherche Scientifique Cell penetrating peptides for intracellular delivery of molecules
WO2014053879A1 (en) 2012-10-04 2014-04-10 Centre National De La Recherche Scientifique Cell penetrating peptides for intracellular delivery of molecules
WO2014053882A1 (en) 2012-10-04 2014-04-10 Centre National De La Recherche Scientifique Cell penetrating peptides for intracellular delivery of molecules
WO2014053881A1 (en) 2012-10-04 2014-04-10 Centre National De La Recherche Scientifique Cell penetrating peptides for intracellular delivery of molecules
US20150329640A1 (en) 2012-12-20 2015-11-19 Bluebird Bio, Inc. Chimeric antigen receptors and immune cells targeting b cell malignancies
ITRM20130054A1 (it) 2013-01-30 2014-07-31 Paolo Gresele Piastrine trasfettate con materiale genetico esogeno e microparticelle derivate da dette piastrine trasfettate, metodo per la loro preparazione e loro usi.
DK2956175T3 (da) 2013-02-15 2017-11-27 Univ California Kimærisk antigenreceptor og fremgangsmåder til anvendelse deraf
MX387665B (es) 2014-12-24 2025-03-18 Aadigen Llc Péptidos, complejos, moléculas de carga y nanopartículas que contienen los mismos.
WO2017179660A1 (ja) 2016-04-14 2017-10-19 国立大学法人岐阜大学 マイクロrna-143誘導体
CA3025523A1 (en) 2016-05-27 2017-11-30 Aadigen, Llc Peptides and nanoparticles for intracellular delivery of genome-editing molecules
US20190211317A1 (en) 2016-05-27 2019-07-11 Aadigen, Llc Peptides and nanoparticles for intracellular delivery of genome-editing molecules
AU2018313940A1 (en) 2017-08-10 2020-03-05 Aadigen, Llc Peptides and nanoparticles for intracellular delivery of virus
AU2018352221B2 (en) 2017-10-16 2024-04-18 Aadigen, Llc Peptides and nanoparticles for intracellular delivery of mRNA
EP3955967A4 (en) 2019-04-17 2023-06-07 Aadigen, LLC PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF MOLECULES
US20230167437A1 (en) 2020-04-24 2023-06-01 Aadigen, Llc Compositions for treating cancer with kras mutations and uses thereof
WO2022020782A1 (en) 2020-07-24 2022-01-27 Aadigen, Llc Compositions and methods for treating viral infections

Similar Documents

Publication Publication Date Title
JP2022529784A5 (enExample)
JP7645601B2 (ja) 薬物送達キャリア及びそれを用いた医薬製剤
US7772201B2 (en) Highly branched HK peptides as effective carriers of siRNA
CN102380103B (zh) 甘露糖修饰巯基化壳聚糖季铵盐纳米粒及其制备方法和应用
Cheng et al. The effect of guanidinylation of PEGylated poly (2-aminoethyl methacrylate) on the systemic delivery of siRNA
WO2021031839A9 (zh) 一种靶向多肽修饰的载药脂蛋白纳米递药系统及其制备和应用
JP2011503070A (ja) 全身遺伝子送達のための自己構築型ミセル様ナノ粒子
FR2715847A1 (fr) Composition contenant des acides nucléiques, préparation et utilisations.
CN114099699A (zh) 一种纳米递送系统及其制备方法和应用
CN111803653A (zh) 可脱混合细胞膜包被的基因递送体系及其制备方法与应用
US11793756B2 (en) Anionic nanocomplexes for nucleic acid delivery
CN113058042B (zh) 一种可鼻喷的稳定递载rna分子的脂质纳米颗粒制备方法
CA3109138A1 (en) Nanoparticles for transfection
CN111135312B (zh) 一种基于肿瘤泛代谢调控的混合纳米制剂的制备与应用
CN106215191A (zh) 一种脑胶质瘤靶向递药系统及其制备方法和用途
CN117618385A (zh) 一种R8-dGR修饰的脂质纳米粒及其用途
CN115151278A (zh) 用于核酸疗法的靶向肿瘤的多肽纳米颗粒递送系统
JP2007145761A (ja) 細胞膜透過性ペプチド修飾多糖−コレステロールまたは多糖−脂質非ウイルス性ベクターおよびその製造方法
WO2023093596A1 (zh) 一种用于有效递送核酸的环状多肽载体及其变化形式
JP2022075622A (ja) 薬物送達キャリア及びそれを用いて多種類の治療剤を共同送達する医薬製剤
CN107998081A (zh) 一种靶向还原响应囊泡纳米药物在制备脑肿瘤治疗药物中的应用
CN117624302A (zh) 一种用于有效递送核酸的分支链结构多肽载体及其变化形式
US8883989B2 (en) Fractalkine binding polynucleotides and methods of use
KR100986604B1 (ko) 신규한 아미노지질을 함유하는 에스아이알엔에이 수송용 유전자 조성물 및 제조방법
CN116236584B (zh) 一种用于高效递送siRNA的多糖-多肽偶联物